广告Discover A New TROP2-Directed ADC For HR+ HER2- Unresectable Or Metastatic Breast Cancer. Is A New Therapy For HR+ HER2- mBC An Option For Your Patients? View The MOA To Learn More
Request A Contact · Resources For Physicians · Dosing & Infusion Guide
广告High homogeneity. Suitable for immunization, neutralizing antibody screening and more. High homogeneity and bioactivity verified. Protocols offered for free.